Cholesterol efflux capacity was inversely associated with risk of all-cause and cardiovascular mortality in both ACS and stable CAD patients, independent of circulating HDL cholesterol level.
Adding cholesterol efflux capacity to a model containing traditional cardiovascular risk factors significantly increased its discriminatory power and predictive ability for all-cause and cardiovascular mortality.
Furthermore, our findings reveal that an increase in circulating HDL-C levels does not enhance cholesterol efflux capacity when its level is over 50 mg/dL in patients with CAD.